Creative Biolabs Advances Pre-targeted In Vivo Imaging with Bioorthogonal Click Chemistry and Site-specific Bioconjugation

Share this news:

-- Creative Biolabs expands its bioorthogonal click chemistry and site-specific bioconjugation services, delivering pre-targeted in vivo imaging solutions that accelerate precision biomedical research in oncology, immunology, neuroscience, and drug development.

Addressing the Core Bottlenecks in In Vivo Imaging

Achieving high-fidelity in vivo imaging remains a major challenge in biomedical research. Conventional PET/CT and fluorescence imaging approaches often suffer from:

  • High background signal due to nonspecific accumulation (e.g., liver uptake)
  • Limited target specificity
  • Interference with native biological processes
  • Poor performance in complex environments such as blood-brain barrier (BBB) systems

Creative Biolabs addresses these limitations through bioorthogonal click chemistry-enabled pre-targeting strategies, enabling high-contrast imaging with minimal biological perturbation.

Bioorthogonal Click Chemistry: Copper-free Precision in Living Systems

Bioorthogonal chemistry has evolved beyond a conceptual framework into a toolkit of highly selective, copper-free reactions suitable for in vivo applications.

Creative Biolabs supports multiple industry-standard bioorthogonal ligation platforms, including:

  • SPAAC (Strain-Promoted Azide–Alkyne Cycloaddition) — copper-free, fast kinetics for in vivo labeling
  • IEDDA (Inverse Electron-Demand Diels–Alder) — ultrafast reaction rates ideal for pre-targeted imaging workflows
  • Staudinger Ligation — biocompatible ligation with minimal off-target effects

These copper-free click chemistry systems eliminate the cytotoxicity associated with Cu(I)-catalyzed reactions, making them particularly suitable for live-cell and preclinical in vivo studies.

Pre-targeted Imaging: Solving Signal-to-Noise Challenges

A major advancement enabled by bioorthogonal chemistry is pre-targeted imaging, which separates targeting and signal generation into two steps:

  • Targeting moiety (e.g., antibody) accumulates at the disease site
  • A small bioorthogonal probe reacts selectively in situ

This approach:

  • Reduces background signal from circulating probes
  • Minimizes off-target accumulation (e.g., hepatic uptake)
  • Enables imaging in challenging systems such as CNS and tumor microenvironments

Compared to traditional direct-labeling strategies, bioorthogonal pre-targeting significantly improves signal-to-noise ratio and temporal resolution.

In Vivo Imaging Solutions for Precision Biomedical Research

Creative Biolabs integrates bioorthogonal chemistry with advanced bioconjugation platforms to deliver:

  • High-resolution molecular imaging with minimal background interference
  • Site-specific labeling for improved reproducibility
  • Compatibility with PET, fluorescence, and multimodal imaging systems

"Traditional imaging methods often struggle with specificity and background noise," said a senior scientist at Creative Biolabs. "By leveraging copper-free bioorthogonal click chemistry, we enable highly selective reactions in vivo, supporting precise visualization in complex biological systems."

Customized Bioconjugation Services: From Concept to Application

Creative Biolabs offers fully customized, site-specific bioconjugation solutions, including:

  • Antibody-drug conjugates (ADCs)
  • Fluorescent and radiolabeled probes
  • Metabolic glycan labeling strategies
  • Protein and peptide modification platforms

Each project is optimized for:

  • Reaction efficiency and stability
  • Batch-to-batch reproducibility
  • Compatibility with preclinical imaging workflows

Compliance Statement

All products and services provided by Creative Biolabs are intended for Research Use Only (RUO) and are designed exclusively for preclinical research applications. They are not intended for diagnostic or therapeutic use in humans.

Download the latest technical guide on bioorthogonal pre-targeted imaging strategies and site-specific bioconjugation approaches: https://www.creative-biolabs.com/bioconjugation/.

About Creative Biolabs

Creative Biolabs is a leading biotechnology company specializing in bioorthogonal click chemistry, site-specific bioconjugation, and in vivo imaging solutions. With extensive expertise in pre-targeted imaging and precision labeling technologies, the company provides customized strategies to support cutting-edge biomedical research worldwide.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 17 Ramsey Road, Shirley, NY 11967, USA
Phone: 6318306441
Website: https://www.creative-biolabs.com/bioconjugation/

Release ID: 89189648

CONTACT ISSUER
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 17 Ramsey Road, Shirley, NY 11967, USA
REVIEWED BY
Editor Profile Picture
This content is reviewed by our News Editor, Diana W..

If you need any help with this piece of content, please contact us through our contact form
SUBSCRIBE FOR MORE